Eli Lilly at peer perform by Bear Stearns

Bear Stearns analyst John Boris gave Eli Lilly & Co. a peer perform rating ahead of the company's third-quarter earnings conference call. Boris projects earnings per share of $0.80, or one cent above consensus and the company's guidance of $0.77 to $0.79. Look for Zyprexa global performance and U.S. Cymbalta sales as the most important data points coming from the third-quarter 2006 release, according to the analyst. Shares of the Indianapolis pharmaceutical company were up 70 cents, or 1.22%, at $58.25. (NYSE: LLY)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.